PCNA and cancer: Several lines of evidences suggest that cancer cells treated with OSCs can lead to the arrest in G2/M phase of the cell cycle through modulating the expressions or activities of cyclins, cyclin-dependent kinases (Cdks) , signaling molecules and histones [6].